These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8606636)

  • 1. Differential beta-cell response to glucose, glucagon, and arginine during progression to type I (insulin-dependent) diabetes mellitus.
    Chaillous L; Rohmer V; Maugendre D; Lecomte P; Maréchaud R; Marre M; Guilhem I; Charbonnel B; Saï P
    Metabolism; 1996 Mar; 45(3):306-14. PubMed ID: 8606636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study.
    Greenbaum CJ; Sears KL; Kahn SE; Palmer JP
    Diabetes; 1999 Jan; 48(1):170-5. PubMed ID: 9892239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of age-related acute insulin response to glucose in subjects at risk for type 1 diabetes: results of a 6-year follow-up study from west-France.
    Bardet S; Joseph MG; Maugendre D; Matthieu E; Chaillous L; Semana G; Limal JM; Allannic H; Charbonnel B; Sai P
    Diabete Metab; 1993; 19(4):372-80. PubMed ID: 8293864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute insulin response to intravenous glucose, glucagon and arginine in some subjects at risk for type 1 (insulin-dependent) diabetes mellitus.
    Bardet S; Rohmer V; Maugendre D; Marre M; Semana G; Limal JM; Allannic H; Charbonnel B; Saï P
    Diabetologia; 1991 Sep; 34(9):648-54. PubMed ID: 1955097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential sensitivity to beta-cell secretagogues in "early," type I diabetes mellitus.
    Ganda OP; Srikanta S; Brink SJ; Morris MA; Gleason RE; Soeldner JS; Eisenbarth GS
    Diabetes; 1984 Jun; 33(6):516-21. PubMed ID: 6373458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
    Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
    Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell responses to intravenous glucose and glucagon in non-diabetic twins of patients with type 1 (insulin-dependent) diabetes mellitus.
    Heaton DA; Lazarus NR; Pyke DA; Leslie RD
    Diabetologia; 1989 Nov; 32(11):814-7. PubMed ID: 2687066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study.
    McCulloch DK; Klaff LJ; Kahn SE; Schoenfeld SL; Greenbaum CJ; Mauseth RS; Benson EA; Nepom GT; Shewey L; Palmer JP
    Diabetes; 1990 May; 39(5):549-56. PubMed ID: 2185106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study of the degrees of insulin resistance and first-phase insulin secretion of beta-cells in metabolic syndrome patients with different glucose tolerance].
    Hong J; Gu WQ; Zhang YF; Guo Y; Chen HM; Zhang LZ; Zhao YJ; Ning G
    Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1952-6. PubMed ID: 14703429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of family history of diabetes on the assessment of beta-cell function.
    Alford FP; Henriksen JE; Rantzau C; Vaag A; Hew LF; Ward GM; Beck-Nielsen H
    Metabolism; 1998 May; 47(5):522-8. PubMed ID: 9591741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients.
    Vardi P; Crisa L; Jackson RA
    Diabetologia; 1991 Feb; 34(2):93-102. PubMed ID: 2065854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients.
    Rakotoambinina B; Timsit J; Deschamps I; Laborde K; Jos J; Boitard C; Assan R; Robert JJ
    Diabetes Care; 1995 Nov; 18(11):1487-90. PubMed ID: 8722075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance.
    Byrne MM; Gliem K; Wank U; Arnold R; Katschinski M; Polonsky KS; Göke B
    Diabetes; 1998 Aug; 47(8):1259-65. PubMed ID: 9703326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.
    Palmer JP; Benson JW; Walter RM; Ensinck JW
    J Clin Invest; 1976 Sep; 58(3):565-70. PubMed ID: 783201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Decrease of early insulin secretion, risk factor of insulin-dependent diabetes. Prospective study in families with diabetic children].
    Robert JJ; Boitard C; Mogenet A; Chevenne D; Roger M; Deschamps I
    Arch Fr Pediatr; 1991 Jan; 48(1):11-7. PubMed ID: 2018414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered islet beta-cell function before the onset of type 1 (insulin-dependent) diabetes mellitus.
    Lo SS; Hawa M; Beer SF; Pyke DA; Leslie RD
    Diabetologia; 1992 Mar; 35(3):277-82. PubMed ID: 1563585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIRarg and AIRgluc as predictors of insulin secretory reserve.
    Robertson RP
    Transplant Proc; 2004 May; 36(4):1040-1. PubMed ID: 15194361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin responses to intravenous glucose, intravenous arginine and a hyperglycaemic clamp in ICA-positive subjects with different degrees of glucose tolerance.
    Rakotoambinina B; Timsit J; Deschamps I; Laborde K; Gautier D; Jos J; Boitard C; Robert JJ
    Diabetes Metab; 1997 Feb; 23(1):43-50. PubMed ID: 9059765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished A-cell secretion in the early phase of type I diabetes mellitus.
    Ganda OP; Srikanta S; Gleason RE; Soeldner JS; Eisenbarth GS
    Metabolism; 1986 Nov; 35(11):1074-7. PubMed ID: 3534518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.